LEILANI GADOR-MARCELINO: Open Payments
NPI 1790335131 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$98 in 4 payments from 3 companies in 2025. Trend: 2023 $80 · 2024 $232 · 2025 $98
Food & beverage: $98
| Company | Payments | Amount |
|---|---|---|
| Melinta Therapeutics, LLC | 2 | $51 |
| Merck Sharp & Dohme LLC | 1 | $30 |
| ABBVIE INC. | 1 | $17 |
Products named: Rezzayo, ZERBAXA, TEFLARO.
Industry payments across NV — which companies pay providers there.
